Cited by 81Economic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of LifeGlobal Cancer Incidence and Screening

The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden

Open access
Hanly, Paul A, Sharp, Linda·2014·BMC Cancer

Abstract

BACKGROUND: Most measures of the cancer burden take a public health perspective. Cancer also has a significant economic impact on society. To assess this economic burden, we estimated years of potential productive life lost (YPPLL) and costs of lost productivity due to premature cancer-related mortality in Ireland. METHODS: All cancers combined and the 10 sites accounting for most deaths in men and in women were considered. To compute YPPLL, deaths in 5-year age-bands between 15 and 64 years were multiplied by average working-life expectancy. Valuation of costs, using the human capital approach, involved multiplying YPPLL by age-and-gender specific gross wages, and adjusting for unemployment and workforce participation. Sensitivity analyses were conducted around retirement age and wage growth, labour force participation, employment and discount rates, and to explore the impact of including household production and caring costs. Costs were expressed in €2009. RESULTS: Total YPPLL was lower in men than women (men = 10,873; women = 12,119). Premature cancer-related mortality costs were higher in men (men: total cost = €332 million, cost/death = €290,172, cost/YPPLL = €30,558; women: total cost = €177 million, cost/death = €159,959, cost/YPPLL = €14,628). Lung cancer had the highest premature mortality cost (€84.0 million; 16.5% of total costs), followed by cancers of the colorectum (€49.6 million; 9.7%), breast (€49.4 million; 9.7%) and brain & CNS (€42.4 million: 8.3%). The total economic cost of premature cancer-related mortality in Ireland amounted to €509.5 million or 0.3% of gross domestic product. An increase of one year in the retirement age increased the total all-cancer premature mortality cost by 9.9% for men and 5.9% for women. The inclusion of household production and caring costs increased the total cost to €945.7 million. CONCLUSION: Lost productivity costs due to cancer-related premature mortality are significant. The higher premature mortality cost in males than females reflects higher wages and rates of workforce participation. Productivity costs provide an alternative perspective on the cancer burden on society and may inform cancer control policy decisions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-14-224

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Through trajectory risk, survivors experience loss of productive functions, financial crises, family tensions and stigma.

    “Through trajectory risk, survivors experience a loss of productive functions, financial crises, family tensions and stigma [42-44].”

    From Empowerment in the treatment of fatigue in breast cancer patients (2021) · cites this paper as [42]

    The Discussion (Economy-level premature mortality cost burden; page unavailable) supports lost productivity, including household production and caring activity, due to premature cancer-related death. It does not establish that survivors experience those losses, financial crises, family tensions, or stigma; the paper measures an economy-level mortality burden rather than those survivor experiences. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 21 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Central Statistics Office Statbank- Quarterly National Household Survey [ http://www.cso.ie/px/pxeirestat/Database/eirestat/Quarterly%20National%20Household%20Survey%20Main%20Results/Quarterly%20National%20Household%20Survey%20Main%20Results_statbank.asp?SP=Quarterly National Household Survey Main Results&Planguage=0]

Cited by

Sorted by citations

Authors
Hanly, P. A., & Sharp, L.
Affiliations
  • National College of Ireland (IE)
  • National Cancer Registry (IE)
Corresponding author
Hanly, Paul A
Venue
BMC Cancer
Published
2014-03-26
Volume
14
Issue
1
Pages
224-224
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2156575488
Cited by
81
References
21
Citations by year
2026: 8 · 2025: 8 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 12 · 2019: 4 · 2018: 9 · 2017: 3 · 2016: 8 · 2015: 5 · 2014: 2
FWCI
14.88
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NORMA (acceptedVersion)
  • TRAP@NCI (National College of Ireland) (acceptedVersion)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion, cc-by)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
cancer mortality, economic burden of cancer, productivity loss, human capital approach, lung cancer, breast cancer, colorectal cancer, brain and central nervous system cancer, retirement age, gender differences, Ireland
MeSH terms
Adolescent, Adult, Efficiency, Female, Humans, Ireland, Life Expectancy, Male, Middle Aged, Neoplasms, Health Care Costs, Cost of Illness, Models, Economic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review